Aclarion's Nociscan Solution Used to Understand Modic Changes in Chronic Low Back Pain Patients
Aclarion's Nociscan Solution Used to Understand Modic Changes in Chronic Low Back Pain Patients
Key Takeaways (TLDR)
Aclarion's Nociscan solution provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
MRS measurement of intradiscal propionic acid can clarify Modic changes (MC) etiology and help stratify MC patients to potentially inform better treatment decisions for cLBP patients.
Aclarion's focus is to provide physicians with new noninvasive information they can use to help make better decisions about patient care.
The results challenge the notion that the disc environment is sterile, and PA levels may be useful for understanding why some patients with MC improve or respond to treatment while others do not.
Why it Matters
This news matters because it highlights innovative research on chronic low back pain, potentially leading to better treatment decisions and personalized care for patients. The use of Nociscan technology to identify biomarkers and its potential impact on improving patient outcomes is a significant development in the healthcare industry.
Summary
Aclarion, Inc., a healthcare technology company, announced the use of its Nociscan solution to better understand Modic changes (MC) in patients suffering from chronic low back pain (cLBP). The study, presented at the 50th International Society for the Study of the Lumbar Spine Annual Meeting 2024, utilized MR Spectroscopy (MRS) to measure intradiscal propionic acid (PA) levels adjacent to vertebral endplates and found that PA levels may be useful for understanding why some patients with MC improve or respond to treatment while others do not. Aclarion’s Nociscan solution is the first evidence-supported SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine.
This news story relied on a press release distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Aclarion's Nociscan Solution Used to Understand Modic Changes in Chronic Low Back Pain Patients.